LncRNA ZFAS1 Combined with SRSF1 Regulate CNPY2 Expression and Leads to Microglia Endoplasmic Reticulum Stress-Induced Spinal Cord Injury
- PMID: 40465066
- DOI: 10.1007/s12035-025-05080-4
LncRNA ZFAS1 Combined with SRSF1 Regulate CNPY2 Expression and Leads to Microglia Endoplasmic Reticulum Stress-Induced Spinal Cord Injury
Abstract
Spinal cord injury (SCI) has a high mortality and disability rate. Endoplasmic reticulum (ER) stress induces neuronal apoptosis and participates in the regulation of SCI. LncRNA ZFAS1 can participate in the regulation of SCI by influencing ER stress; however, its mechanism is worth further exploring. The molecular mechanism of lncRNA ZFAS1 regulating spinal cord injury was evaluated by in vitro and in vivo experiments. We established an SCI model in vitro by inducing mouse microglia (BV-2) with LPS. The regulation of SCI was verified by transfection of shRNA knockdown lncRNA ZFAS1 and CNPY2. The expression levels of related genes and proteins were detected by qPCR and western blot. The proportion of apoptosis was analyzed by flow cytometry and TUNEL staining. RIP and RNA pull down verified that lncRNA ZFAS1 combined with SRSF1 stabilized CNPY2 mRNA. It was verified that lncRNA ZFAS1 promoted ER stress and accelerated SCI injury in SCI mice model. Our results showed that the expression of lncRNA ZFAS1 and CNPY2 increased in SCI cell model, which was related to SCI injury. Knocking down lncRNA ZFAS1 or CNPY2 could inhibit ER stress and reduce apoptosis of BV-2 cells. Inhibition of lncRNA ZFAS1 in SCI mice increased the number of spinal cord neurons and ER stress response, and improved SCI injury in mice. Molecular experiments confirmed that lncRNA ZFAS1 stabilized CNPY2 mRNA by binding to SRSF1. And the lncRNA ZFAS1/CNPY2 axis was involved in regulating ER stress and apoptosis of BV-2 cells. LncRNA ZFAS1 stabilized CNPY2 by combining with SRSF1, which led to ER stress in microglia and promoted SCI. LncRNA ZFAS1 may be a potential target gene for the prevention and treatment of SCI.
Keywords: CNPY2; Endoplasmic reticulum stress; LncRNA ZFAS1; Spinal cord injury.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics Approval and Consent to Participate: All animal experiments were conducted in accordance with the guidelines approved by the Haikou Affiliated Hospital of Central South University Xiangya School of Medicine Ethics Committee (No. 2024-(LS)-194). Consent for Publication: Not applicable. Declaration of Generative AI and AI-Assisted Technologies in the Writing Process: During the preparation of this work, the authors did not use any AI-assisted technology. Conflict of interest: The authors declare no competing interests.
Similar articles
-
Long noncoding RNA ZFAS1 aggravates spinal cord injury by binding with miR-1953 and regulating the PTEN/PI3K/AKT pathway.Neurochem Int. 2021 Jul;147:104977. doi: 10.1016/j.neuint.2021.104977. Epub 2021 Jan 30. Neurochem Int. 2021. PMID: 33524472
-
Dexmedetomidine attenuates neuronal injury after spinal cord ischaemia-reperfusion injury by targeting the CNPY2-endoplasmic reticulum stress signalling.J Cell Mol Med. 2019 Dec;23(12):8173-8183. doi: 10.1111/jcmm.14688. Epub 2019 Oct 18. J Cell Mol Med. 2019. PMID: 31625681 Free PMC article.
-
circ_014260/miR-384/THBS1 aggravates spinal cord injury in rats by promoting neuronal apoptosis and endoplasmic reticulum stress.Am J Transl Res. 2022 Jan 15;14(1):518-533. eCollection 2022. Am J Transl Res. 2022. PMID: 35173872 Free PMC article.
-
lncRNA ZFAS1 Improves Neuronal Injury and Inhibits Inflammation, Oxidative Stress, and Apoptosis by Sponging miR-582 and Upregulating NOS3 Expression in Cerebral Ischemia/Reperfusion Injury.Inflammation. 2020 Aug;43(4):1337-1350. doi: 10.1007/s10753-020-01212-1. Inflammation. 2020. PMID: 32180078
-
Bone Marrow Mesenchymal Stem Cell-Derived Exosomal KLF4 Alleviated Ischemic Stroke Through Inhibiting N6-Methyladenosine Modification Level of Drp1 by Targeting lncRNA-ZFAS1.Mol Neurobiol. 2023 Jul;60(7):3945-3962. doi: 10.1007/s12035-023-03301-2. Epub 2023 Mar 31. Mol Neurobiol. 2023. PMID: 37002530
References
-
- Kim HN, McCrea MR, Li S (2023) Advances in molecular therapies for targeting pathophysiology in spinal cord injury. Expert Opin Ther Targets 27(3):171–187. https://doi.org/10.1080/14728222.2023.2194532 - DOI - PubMed - PMC
-
- Yu M, Wang Z, Wang D, Aierxi M, Ma Z, Wang Y (2023) Oxidative stress following spinal cord injury: from molecular mechanisms to therapeutic targets. J Neurosci Res 101(10):1538–1554. https://doi.org/10.1002/jnr.25221 - DOI - PubMed
-
- Liu Z, Yao X, Jiang W, Li W, Zhu S, Liao C, Zou L, Ding R et al (2020) Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-kappaB signaling pathway and pyroptosis after secondary spinal cord injury. J Neuroinflammation 17(1):90. https://doi.org/10.1186/s12974-020-01751-2 - DOI - PubMed - PMC
-
- Tran AP, Warren PM, Silver J (2018) The biology of regeneration failure and success after spinal cord injury. Physiol Rev 98(2):881–917. https://doi.org/10.1152/physrev.00017.2017 - DOI - PubMed - PMC
-
- Lu E, Tang Y, Chen J, Al Mamun A, Feng Z, Cao L, Zhang X, Zhu Y et al (2023) Stub1 ameliorates ER stress-induced neural cell apoptosis and promotes locomotor recovery through restoring autophagy flux after spinal cord injury. Exp Neurol 368:114495. https://doi.org/10.1016/j.expneurol.2023.114495 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous